Literature DB >> 19709482

Algorithms for the management of overactive bladder.

Richard T Kershen1.   

Abstract

Overactive bladder (OAB) is a highly prevalent and bothersome condition that hampers quality of life in men and women. Increased awareness of available treatment has led growing numbers of patients to seek medical attention in search of relief. Clinical algorithms for the management of OAB would enable physicians who treat these patients to deliver up-to-date, effective care in an expeditious fashion. An algorithmic approach to OAB should allow most patients to receive therapy without the need for an extended evaluation. Patients who fail initial management or have more complicated clinical scenarios should have treatment directed by specialists who can precisely determine the nature of vesicourethral dysfunction underlying their symptoms. This article presents algorithms for the management of OAB in women, men, and patients with neurologic disease.

Entities:  

Mesh:

Year:  2009        PMID: 19709482     DOI: 10.1007/s11934-009-0056-1

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  33 in total

1.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

2.  Surgical treatment for stress urinary incontinence associated with valsalva induced detrusor instability.

Authors:  S R Serels; R R Rackley; R A Appell
Journal:  J Urol       Date:  2000-03       Impact factor: 7.450

3.  Botulinum toxin type A injections for treating neurogenic detrusor overactivity combined with low-compliance bladder in patients with spinal cord lesions.

Authors:  Jakkrit Klaphajone; Wasuwat Kitisomprayoonkul; Supon Sriplakit
Journal:  Arch Phys Med Rehabil       Date:  2005-11       Impact factor: 3.966

4.  Detrusor instability in men: correlation of lower urinary tract symptoms with urodynamic findings.

Authors:  M J Hyman; A Groutz; J G Blaivas
Journal:  J Urol       Date:  2001-08       Impact factor: 7.450

5.  Behavioral therapy to enable women with urge incontinence to discontinue drug treatment: a randomized trial.

Authors:  Kathryn L Burgio; Stephen R Kraus; Shawn Menefee; Diane Borello-France; Marlene Corton; Harry W Johnson; Veronica Mallett; Peggy Norton; Mary P FitzGerald; Kimberly J Dandreo; Holly E Richter; Thomas Rozanski; Michael Albo; Halina M Zyczynski; Gary E Lemack; Toby C Chai; Salil Khandwala; Jan Baker; Linda Brubaker; Anne M Stoddard; Patricia S Goode; Betsy Nielsen-Omeis; Charles W Nager; Kimberly Kenton; Sharon L Tennstedt; John W Kusek; T Debuene Chang; Leroy M Nyberg; William Steers
Journal:  Ann Intern Med       Date:  2008-08-05       Impact factor: 25.391

Review 6.  How to choose the initial drug treatment for overactive bladder.

Authors:  Scott A MacDiarmid
Journal:  Curr Urol Rep       Date:  2007-09       Impact factor: 3.092

7.  Prevalence and burden of overactive bladder in the United States.

Authors:  W F Stewart; J B Van Rooyen; G W Cundiff; P Abrams; A R Herzog; R Corey; T L Hunt; A J Wein
Journal:  World J Urol       Date:  2002-11-15       Impact factor: 4.226

8.  Prevalence and physician awareness of symptoms of urinary bladder dysfunction.

Authors:  Mark Goepel; Josef A Hoffmann; Maria Piro; Herbert Rübben; Martin C Michel
Journal:  Eur Urol       Date:  2002-03       Impact factor: 20.096

Review 9.  Overactive bladder in the male patient: epidemiology, etiology, evaluation, and treatment.

Authors:  William I Jaffe; Alexis E Te
Journal:  Curr Urol Rep       Date:  2005-11       Impact factor: 2.862

10.  Prevalence, evaluation and management of overactive bladder in primary care.

Authors:  Wellman W Cheung; Nadia H Khan; Karmina K Choi; Martin H Bluth; Miriam T Vincent
Journal:  BMC Fam Pract       Date:  2009-01-23       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.